Asia Pacific Bone Grafts & Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Dental), By Country, And Segment Forecasts, 2025 - 2030

December 2024 | 100 pages | ID: AF7AEF255E91EN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 2 Business Days

Asia Pacific Bone Grafts & Substitutes Market Growth & Trends

The Asia Pacific bone grafts & substitutes market size is estimated treach USD 1.06 billion by 2030, expanding at a CAGR of 8.2% from 2025 t2030, according ta new report by Grand View Research, Inc. Increasing the incidence of bone disorders due troad accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order treduce adverse reaction is driving demand for synthetic grafts.

The industry players are continuously trying tdevelop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone. In August 2019, NanoFUSE biologics marked its presence in Thailand with FDA approved NanoFUSE biologics, a bioactive glass with a demineralized bone matrix.

Asia Pacific Bone Grafts & Substitutes Market Report Highlights

• In terms of revenue, the allograft segment dominated the market with a revenue share of 57.6% in 2024. The growth can be attributed tits increased usage in medical procedures and product innovation.
• The Demineralized Bone Matrix (DBM) segment dominated the allografts segment as of 2024 owing tits increased commercial accessibility in a number of standard forms and sources.
• On the basis of application, the spinal fusion segment held the largest revenue share in 2024 owing tthe growing number of spinal fusion procedures and new product approvals for the same.
• The dental segment is expected tshow lucrative growth over the forecast period. The growth can be attributed tthe increasing number of dental implant surgeries and product availability.
• An increasing number of government initiatives and medical tourism is expected tpropel market growth. Moreover, the growing number of bone and joint disorders due tthe increasing aging population is further increasing the growth.

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Segment Definitions
  1.2.1. Material Type
  1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
  1.5.1. Purchased Database
  1.5.2. GVR’s Internal Database
  1.5.3. Secondary Sources
  1.5.4. Primary Research
1.6. Information Analysis
  1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
  1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. ASIA PACIFIC BONE GRAFTS & SUBSTITUTES MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
  3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
  3.3.1. Industry Analysis - Porter’s Five Forces Analysis
    3.3.1.1. Supplier Power
    3.3.1.2. Buyer Power
    3.3.1.3. Substitution Threat
    3.3.1.4. Threat of New Entrants
    3.3.1.5. Competitive Rivalry
  3.3.2. PESTLE Analysis

CHAPTER 4. ASIA PACIFIC BONE GRAFTS & SUBSTITUTES MARKET: MATERIAL TYPE BUSINESS ANALYSIS

4.1. Material Type Market Share, 2024 & 2030
4.2. Material Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
4.4. Allograft
  4.4.1. Allograft Market, 2018 - 2030 (USD Million)
  4.4.2. Demineralized Bone Matrix
    4.4.2.1. Demineralized Bone Matrix Market, 2018 - 2030 (USD Million)
  4.4.3. Others
    4.4.3.1. Others Market, 2018 - 2030 (USD Million)
4.5. Synthetic
  4.5.1. Synthetic Market, 2018 - 2030 (USD Million)
  4.5.2. Ceramics
    4.5.2.1. Ceramics Market, 2018 - 2030 (USD Million)
    4.5.2.2. HAP
      4.5.2.2.1. HAP Market, 2018 - 2030 (USD Million)
    4.5.2.3. Я-TCP
      4.5.2.3.1. Я-TCP Market, 2018 - 2030 (USD Million)
    4.5.2.4. ?-TCP
      4.5.2.4.1. ?-TCP Market, 2018 - 2030 (USD Million)
    4.5.2.5. bi-phasic calcium phosphates (BCP)
      4.5.2.5.1. bi-phasic calcium phosphates (BCP) Market, 2018 - 2030 (USD Million)
    4.5.2.6. Others
      4.5.2.6.1. Others Market, 2018 - 2030 (USD Million)
  4.5.3. Composites
    4.5.3.1. Composites Market, 2018 - 2030 (USD Million)
  4.5.4. Polymers
    4.5.4.1. Polymers Market, 2018 - 2030 (USD Million)
  4.5.5. Bone Morphogenic Proteins (BMP)
    4.5.5.1. Bone Morphogenic Proteins (BMP), 2018 - 2030 (USD Million)

CHAPTER 5. ASIA PACIFIC BONE GRAFTS & SUBSTITUTES MARKET: APPLICATION BUSINESS ANALYSIS

5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Craniomaxillofacial
  5.4.1. Craniomaxillofacial Market, 2018 - 2030 (USD Million)
5.5. Dental
  5.5.1. Dental Market, 2018 - 2030 (USD Million)
5.6. Foot and Ankle
  5.6.1. Foot and Ankle Market, 2018 - 2030 (USD Million)
5.7. Joint Reconstruction
  5.7.1. Joint Reconstruction Market, 2018 - 2030 (USD Million)
5.8. Long Bone
  5.8.1. Long Bone Market, 2018 - 2030 (USD Million)
5.9. Spinal Fusion
  5.9.1. Spinal Fusion Market, 2018 - 2030 (USD Million)

CHAPTER 6. COMPETITIVE LANDSCAPE

6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
  6.5.1. Baxter.
    6.5.1.1. Overview
    6.5.1.2. Financial Performance
    6.5.1.3. Material Type Benchmarking
    6.5.1.4. Strategic Initiatives
  6.5.2. Medical Device Business Services, Inc.
    6.5.2.1. Overview
    6.5.2.2. Financial Performance
    6.5.2.3. Material Type Benchmarking
    6.5.2.4. Strategic Initiatives
  6.5.3. NuVasive, Inc.
    6.5.3.1. Overview
    6.5.3.2. Financial Performance
    6.5.3.3. Material Type Benchmarking
    6.5.3.4. Strategic Initiatives
  6.5.4. Stryker
    6.5.4.1. Overview
    6.5.4.2. Financial Performance
    6.5.4.3. Material Type Benchmarking
    6.5.4.4. Strategic Initiatives
  6.5.5. Medtronic
    6.5.5.1. Overview
    6.5.5.2. Financial Performance
    6.5.5.3. Material Type Benchmarking
    6.5.5.4. Strategic Initiatives
  6.5.6. Zimmer Biomet.
    6.5.6.1. Overview
    6.5.6.2. Financial Performance
    6.5.6.3. Material Type Benchmarking
    6.5.6.4. Strategic Initiatives
  6.5.7. Smith+Nephew
    6.5.7.1. Overview
    6.5.7.2. Financial Performance
    6.5.7.3. Material Type Benchmarking
    6.5.7.4. Strategic Initiatives
  6.5.8. Orthofix Medical Inc.
    6.5.8.1. Overview
    6.5.8.2. Financial Performance
    6.5.8.3. Material Type Benchmarking
    6.5.8.4. Strategic Initiatives
  6.5.9. Wright Medical Group N.V.
    6.5.9.1. Overview
    6.5.9.2. Financial Performance
    6.5.9.3. Material Type Benchmarking
    6.5.9.4. Strategic Initiatives
  6.5.10. Geistlich Pharma AG
    6.5.10.1. Overview
    6.5.10.2. Financial Performance
    6.5.10.3. Material Type Benchmarking
    6.5.10.4. Strategic Initiatives